| 1/3 | US=22 / Câncer Robinson MK, Borghaci H, Adams GP, Weiner LM. Monoclonal antibodies. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 537-48. |
| 2/3 | US=21 / Neurologia Husain SR, Puri RK. Contemporary investigational treatments: immunotoxins for glioma therapy. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 315-35. (Current Clinical Oncology) ISBN 978-1-58829-511-8. GLIOMA DE ALTO GRAU. TERAPIA; IMUNOTOXINAS; IL13-PE; PROTEINA DE FUSAO QUIMERICA; XENOENXERTO; ENSAIO CLINICO |
| 3/3 | US=46 / Câncer Reiter Y, Lev A. Immunotoxins and recombinant immunotoxins in cancer therapy. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 409-41. ISBN 978-3-527-31768-4. IMUNOTOXINAS; IMUNOTOXINAS RECOMBINANTES EM TERAPIA DO CANCER; TERAPIA DO CANCER; IMMUNOTOXINS; ANTICORPOS RECOMBINANTES; TERAPIA-ALVO |